Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akilenxel Injection in CAR-T Treatment of Lymphoma (Observational)
ChiCTR2400089315Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of akilenxel in lymphoma, sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Objective Response Rate, Disease Control Rate and 3 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
akilenxel
03
Conditions
lymphoma
Beyond the preview
Go deeper on ChiCTR2400089315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089315.